The Beauty Health Company (SKIN) has a consensus analyst rating of Hold, based on 13 analysts covering the stock. Of those, 3 recommend buying, 7 recommend holding, and 3 recommend selling.
The analyst consensus price target for SKIN is $1.60, representing a +61.6% upside from the current price of $0.9898. Price targets range from a low of $1.60 to a high of $1.60.
